1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZNF292 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA EMC7 CTRPv2 pan-cancer AAC -0.17 2e-07
mRNA ZNF443 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA RUFY3 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA PIM1 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA NPIPA7 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA TAPT1 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA CTXN2 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA RBM12B CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA KLHDC3 CTRPv2 pan-cancer AAC 0.17 2e-07
Download CSV